Morgan Stanley lowered the firm’s price target on Virgin Galactic (SPCE) to $2.30 from $2.50 and keeps an Underweight rating on the shares after the company announced a multi-step capital realignment on December 9, including the repurchase and retirement of about $355M of its 2.5% 2027 convertible notes; the issuance of about $203M of 9.8% notes due in 2028; and selling $46M of its common stock. The capital realignment removes near-term debt pressure and extends the runway into 2028, but renews investor questions around commercialization timing, the analyst tells investors.
Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on SPCE:
- Blue Origin, SpaceX race to bring data centers to space, WSJ reports
- EchoStar jumps on SpaceX IPO talk, Morgan Stanley upgrade
- Musk’s SpaceX targets 2026 IPO at valuation of $1.5T, Bloomberg says
- Virgin Galactic files to sell $45.59M of common stock
- Virgin Galactic Announces Capital Realignment Transactions
